1-5 of 5
Honghua H. Jiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects. Diabetes Care 2011;34: 2496–2501

Open Access
Amparo de la Peña, Matthew Riddle, Linda A. Morrow, Honghua H. Jiang, Helle Linnebjerg, Adam Scott, Khin M. Win, Marcus Hompesch, Kenneth F. Mace, Jennie G. Jacobson, Jeffrey A. Jackson
Journal: Diabetes Care
Diabetes Care 2014;37(8):2414
https://doi.org/10.2337/dc14-er08
Published: 12 July 2014
View articletitled, Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects. Diabetes Care 2011;34: 2496–2501
Open the PDF for Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects. Diabetes Care 2011;34: 2496–2501 in another window
Journal Articles

Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes

Open Access
Bruce H.R. Wolffenbuttel, MD, William H. Herman, MD, Jorge L. Gross, MD, Mala Dharmalingam, MD, Honghua H. Jiang, PHD, Dana S. Hardin, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):2931–2936
https://doi.org/10.2337/dc12-2711
Published: 14 September 2013
View articletitled, Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes
Open the PDF for Ethnic Differences in Glycemic Markers in Patients With Type 2 Diabetes in another window
Journal Articles

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects

Open Access
Amparo de la Peña, PHD, Matthew Riddle, MD, Linda A. Morrow, MD, Honghua H. Jiang, PHD, Helle Linnebjerg, PHD, Adam Scott, BS, Khin M. Win, MBBS, Marcus Hompesch, MD, Kenneth F. Mace, PHD, Jennie G. Jacobson, PHD, Jeffrey A. Jackson, MD
Journal: Diabetes Care
Diabetes Care 2011;34(12):2496–2501
https://doi.org/10.2337/dc11-0721
Published: 14 November 2011
View articletitled, Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
Open the PDF for Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects in another window
Includes: Supplementary data
Journal Articles

The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine

Open Access
John B. Buse, MD, Bruce H.R. Wolffenbuttel, MD, William H. Herman, MD, Stephen Hippler, MD, Sherry A. Martin, MD, Honghua H. Jiang, PHD, Sylvia K. Shenouda, PHD, Jessie L. Fahrbach, MD
Journal: Diabetes Care
Diabetes Care 2011;34(2):249–255
https://doi.org/10.2337/dc10-1701
Published: 20 January 2011
View articletitled, The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine
Open the PDF for The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial: Comparing the durability of lispro mix 75/25 and glargine in another window
Includes: Supplementary data
Journal Articles

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

Open Access
John B. Buse, MD, PHD, Bruce H.R. Wolffenbuttel, MD, PHD, William H. Herman, MD, MPH, Natalie K. Shemonsky, MD, Honghua H. Jiang, PHD, Jessie L. Fahrbach, MD, Jamie L. Scism-Bacon, PHD, Sherry A. Martin, MD
Journal: Diabetes Care
Diabetes Care 2009;32(6):1007–1013
https://doi.org/10.2337/dc08-2117
Published: 31 March 2009
View articletitled, DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes
Open the PDF for DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes in another window
Includes: Supplementary data